Althea Awarded NIH Toxicology Grant | GenomeWeb

NEW YORK, June 23 (GenomeWeb News) - Althea Technologies said today that it has received a Phase I Small Business Innovation Research grant from the National Institutes of Health, by way of the National Institute on Deafness and Other Communication Disorders, to develop a low cost mechanism for translating gene-expression-based research in toxicology into validated, high-throughput, expression screens for the asses

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.